bioRxivCancer BiologyPreprint
A latent variable model for evaluating mutual exclusivity and co-occurrence between driver mutations in cancer
Abstract
A key challenge in cancer genomics is understanding the functional relationships and dependencies between combinations of somatic mutations that drive cancer development. Such driver mutations frequently exhibit patterns of mutual exclusivity or co-occurrence across tumors, and many methods have been developed to identify such dependency patterns from bulk DNA sequencing data of a cohort of patients. However, while mutual exclusivity and co-occurrence are described as properties of driver mutations, existing methods do not explicitly disentangle functional, driver mutations from neutral, passenger mutations. In particular, nearly all existing methods evaluate mutual exclusivity or co-occurrence at the gene level, marking a gene as mutated if any mutation - driver or passenger - is present. Since some genes have a large number of passenger mutations, existing methods either restrict their analyses to a small subset of suspected driver genes - limiting their ability to identify novel dependencies - or make spurious inferences of mutual exclusivity and co-occurrence involving genes with many passenger mutations. We introduce DIALECT, an algorithm to identify dependencies between pairs of driver mutations from somatic mutation counts. We derive a latent variable mixture model for drivers and passengers that combines existing probabilistic models of passenger mutation rates with a latent variable describing the unknown status of a mutation as a driver or passenger. We use an expectation maximization (EM) algorithm to estimate the parameters of our model, including the rates of mutually exclusivity and co-occurrence between drivers. We demonstrate that DIALECT more accurately infers mutual exclusivity and co-occurrence between driver mutations compared to existing methods on both simulated mutation data and somatic mutation data from 5 cancer types in The Cancer Genome Atlas (TCGA).
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Co-mutation and exclusion analysis in human tumors, a means for cancer biology studies and treatment design
S. Ochoa, E. Martinez-Perez, … C. Marino-Buslje·bioRxiv·Aug 30, 2017
- A Statistical Framework for Evolutionary Analysis of Recurrent Somatic Mutations in Cancers
X. Gu·bioRxiv·Apr 10, 2020
- Systematic identification of cancer driving signaling pathways based on mutual exclusivity of genomic alterations
Özgün Babur, Mithat Gönen, … Emek Demir·Genome BiologyPeer-reviewed·Feb 26, 2015
- Identification of outcome-related driver mutations in cancer using conditional co-occurrence distributions
VICTOR TREVINO, Emmanuel Martinez-Ledesma, Jose Gerardo Tamez-Pena·bioRxiv·Sep 16, 2016
- A novel independence test for somatic alterations in cancer shows that biology drives mutual exclusivity but chance explains co-occurrence
Sander Canisius, John Martens, Lodewyk Wessels·bioRxiv·Aug 3, 2016
- Tree of mutually exclusive oncogenes
M. M. Neyshabouri, J. Lagergren·bioRxiv·Feb 7, 2022